Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) 483, Dec 2012

Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) 483, Dec 2012

Atul Agrawal FDA, Peter Baker FDA$119.00

FDA investigators audited the Sun Pharmaceutical Industries (prev. Ranbaxy Toansa) facility in Punjab, India and issued inspectional observations (via FDA 483) on 14 Dec 2012.

Buy This DocumentBuy 1-Year 483 Access

Product details

  • Inspection end: 14 Dec 2012
  • Location: Punjab, India